Cervical cancer remains one of the most preventable yet deadly cancers affecting women in India. Despite advances in medical science, thousands of women continue to lose their lives each year due to late diagnosis and inadequate awareness. Recognising this public health challenge, the Government of India launched a nationwide Human Papillomavirus (HPV) vaccination campaign on 28 February 2026, marking a significant milestone in preventive healthcare. The initiative aims not only to reduce the burden of cervical cancer but also to strengthen India’s commitment to women’s health and universal healthcare.

Understanding HPV and Cervical Cancer

Human Papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. While many HPV infections resolve naturally, persistent infection with high-risk strains—particularly HPV-16 and HPV-18—can lead to cervical cancer over time. According to medical research, nearly 99% of cervical cancer cases are linked to HPV infection, making vaccination one of the most effective preventive measures available.

India bears a disproportionate share of the global burden of cervical cancer, accounting for nearly one-fourth of all cases worldwide. Every year, more than 1.2 lakh women are diagnosed, and nearly 80,000 women lose their lives to the disease. Since cervical cancer develops gradually over several years, timely vaccination offers an opportunity to prevent the disease before it begins.

India’s National HPV Vaccination Campaign

The Government of India launched a nationwide HPV vaccination programme targeting 1.15 crore girls aged 14–15 years. The objective is to immunise girls before they are exposed to HPV, thereby significantly reducing their lifetime risk of developing cervical cancer.

Key features of the programme include:

• Target Group: Girls who attain the age of 14 years, when the vaccine is most effective.
• Vaccine Used: Gardasil-4, which protects against HPV types 16, 18, 6 and 11.
• Single-Dose Schedule: Following WHO recommendations, India has adopted a single-dose vaccination strategy, simplifying implementation while maintaining effectiveness.
• Free Vaccination: Vaccines are provided free of cost at government health facilities such as Ayushman Arogya Mandirs and district hospitals.
• Digital Registration: Parents can register through the U-WIN digital immunisation platform, improving accessibility and monitoring.

Mandsaur: A Model for Successful Implementation

One of the most inspiring examples of effective implementation has emerged from Mandsaur district in Madhya Pradesh, where local authorities demonstrated how data-driven governance can improve public health outcomes.

The district administration integrated multiple government databases, including:

• Rashtriya Bal Swasthya Karyakram (RBSK)
• SAMAGRA MP
• Ladli Laxmi Yojana

By combining these databases with door-to-door surveys and school records, officials identified eligible girls who might otherwise have been left out. Village-level master lists and micro-planning enabled targeted outreach in vulnerable communities.

Overcoming Vaccine Hesitancy

The programme also addressed one of the biggest challenges in HPV vaccination—public hesitation and misinformation.

Health workers organised:

• Community awareness campaigns,
• Counselling sessions,
• School-based awareness programmes,
• Parent interactions,
• Participation of religious leaders, local influencers, and healthcare professionals.

Rather than relying solely on administrative orders, the campaign focused on building public trust through communication and scientific awareness.

Why HPV Vaccination Matters

HPV vaccination offers several long-term benefits:

• Prevents the majority of cervical cancer cases.
• Reduces healthcare costs associated with cancer treatment.
• Protects adolescent girls before exposure to the virus.
• Improves women’s reproductive health outcomes.
• Supports India’s commitment to preventive healthcare under Universal Health Coverage.

Countries that introduced HPV vaccination programmes earlier have already reported substantial declines in HPV infections and precancerous cervical lesions.

Challenges Ahead

Despite encouraging progress, several obstacles remain:

• Low awareness regarding cervical cancer.
• Social stigma surrounding reproductive health.
• Vaccine hesitancy in rural communities.
• Gender-based health inequalities.
• Logistical challenges in reaching remote populations.

Continuous public education and community engagement will be essential to achieve nationwide success.

The Way Forward

To maximise the impact of HPV vaccination, India should:

• Expand awareness campaigns through schools and colleges.
• Strengthen digital monitoring using platforms like U-WIN.
• Train healthcare workers in community counselling.
• Integrate vaccination with adolescent health programmes.
• Encourage collaboration among government agencies, educational institutions, and civil society.

Conclusion

India’s HPV vaccination programme represents more than a public health initiative—it is an investment in the future health of millions of young girls. By combining scientific innovation, digital governance, and community participation, the country has taken a decisive step towards eliminating cervical cancer as a public health threat. The success of models such as Mandsaur demonstrates that with effective planning and public trust, preventive healthcare can transform lives and protect future generations.